Hong Kong's Fullshare says critical research report 'misleading'

Fullshare Holdings

02/05/2017 14:50

HONG KONG, May 2 (Reuters) - Hong Kong property and 
healthcare group Fullshare Holdings Ltd  0607.HK  said on 
Tuesday allegations by Glaucus Research that caused its shares 
to plunge last week were "misleading and groundless". 
    California-based Glaucus Research Group, in a report last 
week, queried Fullshare's stock trading patterns, its valuation 
and asset disposals.  urn:newsml:reuters.com:*:nL4N1HX4VR 
    Saying the report comprised "irresponsible speculations," 
Fullshare said in a filing to the Hong Kong exchange that the 
company was consulting its legal advisers and would consider 
taking legal actions against Glaucus. 
    Glaucus, whose website does not have a phone number, did not 
immediately respond to an email from Reuters seeking comment. 
    Fullshare said it would consider a share repurchase and 
other measures to protect shareholders' interests. 
    Glaucus's report, the latest from an independent researcher 
questioning corporate practices at a Chinese company, triggered 
a trading suspension in Fullshare shares on April 25. The 
company has requested a resumption on May 4. 
 
 (Reporting by Meg Shen; Editing by Mark Potter) 
 ((meg.shen@thomsonreuters.com; 852-28436901; Reuters Messaging: 
meg.shen.thomsonreuters.com@reuters.net)) 
 
Keywords: FULLSHARE HLDG STOCKS/